<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00448812</url>
  </required_header>
  <id_info>
    <org_study_id>05-01</org_study_id>
    <nct_id>NCT00448812</nct_id>
  </id_info>
  <brief_title>AIR Extension Study - Long-Term Safety of Alair Treated Subjects</brief_title>
  <acronym>AIRx</acronym>
  <official_title>Extension Study for the Multicenter Randomized Clinical Trial of the AlairÂ® System for the Bronchial Thermoplasty Treatment of Asthma (NCT00214526)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to gather additional safety data for subjects who&#xD;
      previously completed the one-year study entitled: &quot;Multicenter Randomized Clinical Trial of&#xD;
      the Alair System for the Bronchial Thermoplasty Treatment of Asthma&quot; (Protocol #0602-20,&#xD;
      NCT00214526) sponsored by Asthmatx, Inc. Study Subjects who were assigned to the Control&#xD;
      Group who elect to participate in this extension study will be followed for an additional two&#xD;
      (2) - year period beyond the PREDECESSOR STUDY'S one-year endpoint. Subjects treated with the&#xD;
      Alair System who elect to participate in this extension study will be followed for an&#xD;
      additional four (4)- year period beyond the PREDECESSOR STUDY'S one-year endpoint.&#xD;
&#xD;
      All treatments with the Alair System were completed in the PREDECESSOR STUDY (NCT00214526).&#xD;
      The current study is designed solely to collect longer-term follow-up data on the effects of&#xD;
      the treatments. The data will be of the same type that was collected in the PREDECESSOR STUDY&#xD;
      (NCT00214526), including spirometry, physical examinations, review of symptoms, use of&#xD;
      maintenance and rescue medications, and response to Methacholine challenge.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a multicenter study conducted only at the clinical sites that participated in&#xD;
      the PREDECESSOR STUDY (NCT00214526).&#xD;
&#xD;
      Written, informed consent will be obtained prior to performing any study procedures.&#xD;
      Enrollment will be limited to only those subjects who were in either the Control or Treatment&#xD;
      groups of the PREDECESSOR STUDY (NCT00214526).&#xD;
&#xD;
      The present study will extend the follow-up evaluation of subjects from the PREDECESSOR STUDY&#xD;
      (NCT00214526) to 3 years post-treatment for the Control Subjects and 5 years post-treatment&#xD;
      for Alair-Treated Subjects. These evaluations will consist of two (Control Group) to four&#xD;
      (Alair Group) additional study visits corresponding to the two-year, three-year, four-year&#xD;
      and five-year time points following completion of Alair treatments (or similar time point for&#xD;
      control subjects) in the PREDECESSOR STUDY (NCT00214526). For consistency with the&#xD;
      PREDECESSOR STUDY (NCT00214526), ideally the subject's drug therapy should continue to be&#xD;
      consistent with the Global Initiative for Asthma (GINA) Guidelines for the severity of the&#xD;
      subject's asthma. Any changes in maintenance levels of asthma medications should be&#xD;
      documented.&#xD;
&#xD;
      The goal of this follow-up study is to enroll all subjects who participated in the&#xD;
      PREDECESSOR STUDY (NCT00214526). Inclusion of subjects from the treatment arm will allow for&#xD;
      the assessment of long-term safety of the Alair procedure for up to 5 years post treatment&#xD;
      with the Alair System. Inclusion of subjects from the Control arm will allow for appropriate&#xD;
      analysis of long-term effectiveness data for up to 3 years post &quot;treatment&quot;.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects With Any Respiratory Adverse Event</measure>
    <time_frame>12 Month periods out to 5 years</time_frame>
    <description>There is not one specific primary outcome measure. The primary objective of this study is to gather additional, longer-term safety data in subjects who participated in the AIR Trial (Protocol #0602-20), called the AIR PREDECESSOR STUDY in the AIR Extension Report (NCT00214526). The 'Percentage of Subjects with any Respiratory Adverse Event' was chosen to be the primary outcome measure because it is the first described in the final study report.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Health Care Usage</measure>
    <time_frame>12 Month periods out to 5 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of Respiratory Adverse Events</measure>
    <time_frame>12 Month periods out to 5 years</time_frame>
    <description>Number of respiratory adverse events per subject</description>
  </other_outcome>
  <other_outcome>
    <measure>Forced Expiratory Volume in 1 Second (FEV1) - % Predicted</measure>
    <time_frame>12 Month periods out to 5 years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Alair Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects from PREDECESSOR STUDY (NCT00214526) treated with conventional therapy with ICS+LABA (inhaled corticosteroid + long-acting beta-agonist) plus Bronchial Thermoplasty with the Alair System.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group subjects from PREDECESSOR STUDY (NCT00214526).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bronchial Thermoplasty with the Alair System</intervention_name>
    <description>Treatment of airways with the Alair System (Bronchial Thermoplasty) in the PREDECESSOR STUDY (NCT00214526).</description>
    <arm_group_label>Alair Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject who participated in the PREDECESSOR STUDY entitled &quot;Multicenter Randomized&#xD;
             Clinical Trial of the Alair System for the Bronchial Thermoplasty Treatment of&#xD;
             Asthma&quot;(Protocol # 0602-20, NCT00214526).&#xD;
&#xD;
          2. Subject who is able to read, understand, and provide written Informed Consent.&#xD;
&#xD;
          3. Subject who is able to comply with the study protocol, including requirements for&#xD;
             taking and abstaining from medications, and complete all study required visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subject participating in another clinical trial involving respiratory intervention&#xD;
             that could affect the outcome measures of this study, either within 6 weeks of study&#xD;
             enrollment, or during the study period.&#xD;
&#xD;
          2. Subject with a newly diagnosed (since exiting from the PREDECESSOR STUDY) psychiatric&#xD;
             disorder which in the judgment of the investigator could interfere with provision of&#xD;
             informed consent, completion of tests, therapy, or follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Narinder S Shargill, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Asthmatx, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Irmandade Santa Casa de Misericordia de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>CEP 90035 074</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Laval, Laval University</name>
      <address>
        <city>Sainte-Foy</city>
        <state>Quebec</state>
        <zip>G1V 4GS</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gartnavel General Hospital, Univ. Glasgow</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G12 0YN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Lung Research Center, Univ. Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Canada</country>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Laviolette M, Shargill NS, Cox G; AIR Trial Study Group. Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med. 2011 Feb 11;11:8. doi: 10.1186/1471-2466-11-8.</citation>
    <PMID>21314924</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 16, 2007</study_first_submitted>
  <study_first_submitted_qc>March 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2007</study_first_posted>
  <results_first_submitted>July 27, 2015</results_first_submitted>
  <results_first_submitted_qc>January 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 17, 2021</results_first_posted>
  <disposition_first_submitted>February 10, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>February 11, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 17, 2021</disposition_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alair System</keyword>
  <keyword>Bronchial Thermoplasty</keyword>
  <keyword>Long-term Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Alair</title>
          <description>Alair-treated subjects from AIR PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Control subjects from AIR PREDECESSOR STUDY (NCT00214526).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Year 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Year 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Missed visit but remained in study</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Year 3</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missed visit but remained in study</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Year 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="0">Control group subjects exited from study after completing Year 3 evaluation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="0">Control group subjects exited from study after completing Year 3 evaluation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Year 5</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="0">Control group subjects exited from study after completing Year 3 evaluation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="0">Control group subjects exited from study after completing Year 3 evaluation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Missed visit but remained in study</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Alair Treatment</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY.</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Control group subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="69"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" spread="11.21"/>
                    <measurement group_id="B2" value="40.88" spread="12.13"/>
                    <measurement group_id="B3" value="40.30" spread="11.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (cm)</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="166.17" spread="9.64"/>
                    <measurement group_id="B2" value="164.83" spread="7.72"/>
                    <measurement group_id="B3" value="165.70" spread="8.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.37" spread="23.31"/>
                    <measurement group_id="B2" value="77.71" spread="16.95"/>
                    <measurement group_id="B3" value="76.84" spread="21.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Inhaled Corticosteroid Dose</title>
          <description>Dose of Beclomethasone. All other inhaled corticosteroid doses were converted to their equivalent doses of Beclomethasone.</description>
          <units>mcg (micrograms)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1291.11" spread="862.10"/>
                    <measurement group_id="B2" value="1135.42" spread="1030.46"/>
                    <measurement group_id="B3" value="1236.96" spread="919.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Long-acting Beta Agonists (LABA) Dose</title>
          <description>Dose of Salmeterol. All other LABA doses were converted to their equivalent doses of Salmeterol.</description>
          <units>mcg (micrograms)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108.89" spread="33.78"/>
                    <measurement group_id="B2" value="100.00" spread="14.74"/>
                    <measurement group_id="B3" value="105.80" spread="28.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Methacholine PC20</title>
          <description>PC20 is the provocative concentration required to achieve a 20% fall in forced expired volume in one second (FEV1).</description>
          <units>mg/ml</units>
          <param>Geometric Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.25" lower_limit="0.2" upper_limit="0.4"/>
                    <measurement group_id="B2" value="0.28" lower_limit="0.1" upper_limit="0.6"/>
                    <measurement group_id="B3" value="0.26" lower_limit="0.1" upper_limit="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Asthma Control Questionnaire (ACQ) Overall Score</title>
          <description>The ACQ has 7 questions (the top scoring 5 symptoms, FEV1% predicted and daily rescue bronchodilator use). Patients are asked to recall how their asthma has been during the previous week and to respond to the symptom and bronchodilator use questions on a 7-point scale (0=no impairment, 6= maximum impairment). Clinic staff score the FEV1% predicted on a 7-point scale. The questions are equally weighted and the ACQ score is the mean of the 7 questions and therefore between 0 (totally controlled) and 6 (severely uncontrolled).</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>LABA Stable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.39" spread="0.68"/>
                    <measurement group_id="B2" value="1.29" spread="0.7"/>
                    <measurement group_id="B3" value="1.36" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LABA Withdrawal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.50" spread="0.97"/>
                    <measurement group_id="B2" value="2.08" spread="0.90"/>
                    <measurement group_id="B3" value="2.35" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Asthma Quality of Life Questionnaire (AQLQ) Score</title>
          <description>There are 32 questions in the AQLQ and they are in 4 domains (symptoms, activity limitation, emotional function and environmental stimuli). Patients are asked to think about how they have been during the previous two weeks and to respond to each of the 32 questions on a 7-point scale (7 = not impaired at all - 1 = severely impaired). The overall AQLQ score is the mean of all 32 responses and the individual domain scores are the means of the items in those domains.</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>LABA Stable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.65" spread="0.99"/>
                    <measurement group_id="B2" value="5.62" spread="0.92"/>
                    <measurement group_id="B3" value="5.64" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LABA Withdrawal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.88" spread="1.30"/>
                    <measurement group_id="B2" value="4.84" spread="1.40"/>
                    <measurement group_id="B3" value="4.86" spread="1.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects With Any Respiratory Adverse Event</title>
        <description>There is not one specific primary outcome measure. The primary objective of this study is to gather additional, longer-term safety data in subjects who participated in the AIR Trial (Protocol #0602-20), called the AIR PREDECESSOR STUDY in the AIR Extension Report (NCT00214526). The 'Percentage of Subjects with any Respiratory Adverse Event' was chosen to be the primary outcome measure because it is the first described in the final study report.</description>
        <time_frame>12 Month periods out to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alair Year 1</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 1.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O2">
            <title>Alair Year 2</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 2.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O3">
            <title>Alair Year 3</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 3.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O4">
            <title>Alair Year 4</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 4.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O5">
            <title>Alair Year 5</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 5.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O6">
            <title>Control Year 1</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 1.</description>
          </group>
          <group group_id="O7">
            <title>Control Year 2</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 2.</description>
          </group>
          <group group_id="O8">
            <title>Control Year 3</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects With Any Respiratory Adverse Event</title>
          <description>There is not one specific primary outcome measure. The primary objective of this study is to gather additional, longer-term safety data in subjects who participated in the AIR Trial (Protocol #0602-20), called the AIR PREDECESSOR STUDY in the AIR Extension Report (NCT00214526). The 'Percentage of Subjects with any Respiratory Adverse Event' was chosen to be the primary outcome measure because it is the first described in the final study report.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="42"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="18"/>
                    <measurement group_id="O7" value="13"/>
                    <measurement group_id="O8" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Health Care Usage</title>
        <time_frame>12 Month periods out to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alair Year 1</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 1.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O2">
            <title>Alair Year 2</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 2.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O3">
            <title>Alair Year 3</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 3.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O4">
            <title>Alair Year 4</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 4.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O5">
            <title>Alair Year 5</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 5.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O6">
            <title>Control Year 1</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 1.</description>
          </group>
          <group group_id="O7">
            <title>Control Year 2</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 2.</description>
          </group>
          <group group_id="O8">
            <title>Control Year 3</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Health Care Usage</title>
          <units>Number events per subject</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="42"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hospitalizations for Respiratory Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.25"/>
                    <measurement group_id="O2" value="0.07" spread="0.25"/>
                    <measurement group_id="O3" value="0.07" spread="0.46"/>
                    <measurement group_id="O4" value="0.02" spread="0.15"/>
                    <measurement group_id="O5" value="0.02" spread="0.15"/>
                    <measurement group_id="O6" value="0.00" spread="0.00"/>
                    <measurement group_id="O7" value="0.00" spread="0.00"/>
                    <measurement group_id="O8" value="0.05" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emergency Room (ER) Visits for Respiratory Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.21"/>
                    <measurement group_id="O2" value="0.07" spread="0.25"/>
                    <measurement group_id="O3" value="0.07" spread="0.34"/>
                    <measurement group_id="O4" value="0.14" spread="0.47"/>
                    <measurement group_id="O5" value="0.05" spread="0.22"/>
                    <measurement group_id="O6" value="0.00" spread="0.00"/>
                    <measurement group_id="O7" value="0.13" spread="0.34"/>
                    <measurement group_id="O8" value="0.14" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unscheduled Physician Office Visits for Respiratory Symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.42" spread="0.72"/>
                    <measurement group_id="O2" value="0.18" spread="0.44"/>
                    <measurement group_id="O3" value="0.44" spread="0.70"/>
                    <measurement group_id="O4" value="0.70" spread="1.21"/>
                    <measurement group_id="O5" value="0.48" spread="0.94"/>
                    <measurement group_id="O6" value="0.42" spread="0.72"/>
                    <measurement group_id="O7" value="0.25" spread="0.74"/>
                    <measurement group_id="O8" value="0.29" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Respiratory Adverse Events</title>
        <description>Number of respiratory adverse events per subject</description>
        <time_frame>12 Month periods out to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alair Year 1</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 1.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O2">
            <title>Alair Year 2</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 2.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O3">
            <title>Alair Year 3</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 3.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O4">
            <title>Alair Year 4</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 4.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O5">
            <title>Alair Year 5</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 5.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O6">
            <title>Control Year 1</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 1.</description>
          </group>
          <group group_id="O7">
            <title>Control Year 2</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 2.</description>
          </group>
          <group group_id="O8">
            <title>Control Year 3</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Respiratory Adverse Events</title>
          <description>Number of respiratory adverse events per subject</description>
          <units>Number events per subject</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
                <count group_id="O2" value="45"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="43"/>
                <count group_id="O5" value="42"/>
                <count group_id="O6" value="24"/>
                <count group_id="O7" value="24"/>
                <count group_id="O8" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="4.2"/>
                    <measurement group_id="O2" value="1.2" spread="1.6"/>
                    <measurement group_id="O3" value="1.3" spread="1.9"/>
                    <measurement group_id="O4" value="1.2" spread="1.6"/>
                    <measurement group_id="O5" value="1.1" spread="2.2"/>
                    <measurement group_id="O6" value="3.1" spread="3.7"/>
                    <measurement group_id="O7" value="1.2" spread="1.1"/>
                    <measurement group_id="O8" value="1.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Forced Expiratory Volume in 1 Second (FEV1) - % Predicted</title>
        <time_frame>12 Month periods out to 5 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alair Year 1</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 1.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O2">
            <title>Alair Year 2</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 2.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O3">
            <title>Alair Year 3</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 3.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O4">
            <title>Alair Year 4</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 4.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O5">
            <title>Alair Year 5</title>
            <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526), Year 5.&#xD;
Bronchial Thermoplasty with the Alair System: Treatment of airways with the Alair System in the PREDECESSOR STUDY</description>
          </group>
          <group group_id="O6">
            <title>Control Year 1</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 1.</description>
          </group>
          <group group_id="O7">
            <title>Control Year 2</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 2.</description>
          </group>
          <group group_id="O8">
            <title>Control Year 3</title>
            <description>Control group subjects from PREDECESSOR STUDY (NCT00214526) Year 3.</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Expiratory Volume in 1 Second (FEV1) - % Predicted</title>
          <units>percentage predicted</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="35"/>
                <count group_id="O4" value="36"/>
                <count group_id="O5" value="35"/>
                <count group_id="O6" value="19"/>
                <count group_id="O7" value="23"/>
                <count group_id="O8" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Bronchodilator Off-LABA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.0" spread="14.0"/>
                    <measurement group_id="O2" value="73.5" spread="15.0"/>
                    <measurement group_id="O3" value="73.9" spread="12.6"/>
                    <measurement group_id="O4" value="74.3" spread="15.0"/>
                    <measurement group_id="O5" value="70.6" spread="14.6"/>
                    <measurement group_id="O6" value="71.6" spread="11.6"/>
                    <measurement group_id="O7" value="74.8" spread="10.6"/>
                    <measurement group_id="O8" value="70.1" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Bronchodilator Off-LABA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" spread="13.3"/>
                    <measurement group_id="O2" value="85.0" spread="13.1"/>
                    <measurement group_id="O3" value="85.1" spread="11.6"/>
                    <measurement group_id="O4" value="84.6" spread="14.2"/>
                    <measurement group_id="O5" value="83.5" spread="13.5"/>
                    <measurement group_id="O6" value="82.2" spread="8.5"/>
                    <measurement group_id="O7" value="86.3" spread="9.7"/>
                    <measurement group_id="O8" value="80.7" spread="19.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Year 1 Post-Treatment out to 5 years for Alair participants, Year 1 Post-Treatment out to 3 years for Control participants.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Alair - Year 1</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E2">
          <title>Alair - Year 2</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E3">
          <title>Alair - Year 3</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E4">
          <title>Alair - Year 4</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E5">
          <title>Alair - Year 5</title>
          <description>Alair treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E6">
          <title>Control - Year 1</title>
          <description>Control treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E7">
          <title>Control - Year 2</title>
          <description>Control treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
        <group group_id="E8">
          <title>Control - Year 3</title>
          <description>Control treated subjects from PREDECESSOR STUDY (NCT00214526).</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sepsis</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Left Leg Fracture</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Tubal obstruction</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Nasosinusal polyps</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Knee surgery</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Laparotomy</sub_title>
                <description>Non-respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="45"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="43"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="43"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="42"/>
                <counts group_id="E6" subjects_affected="19" subjects_at_risk="24"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="11" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Ear infection</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="42"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Non-Respiratory</description>
                <counts group_id="E1" events="36" subjects_affected="13" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="43"/>
                <counts group_id="E4" events="8" subjects_affected="7" subjects_at_risk="43"/>
                <counts group_id="E5" events="8" subjects_affected="6" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" events="4" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="45"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="5" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="29" subjects_affected="17" subjects_at_risk="45"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" events="6" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="9" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="40" subjects_affected="20" subjects_at_risk="45"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="43"/>
                <counts group_id="E5" events="7" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E6" events="22" subjects_affected="12" subjects_at_risk="24"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="21" subjects_affected="13" subjects_at_risk="45"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Nocturnal dyspnoea</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="7" subjects_affected="5" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="14" subjects_affected="9" subjects_at_risk="45"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="6" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="43"/>
                <counts group_id="E4" events="6" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E7" events="4" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Sputum discoloured</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="45"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="45"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="43"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="43"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" events="3" subjects_affected="2" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="15" subjects_affected="10" subjects_at_risk="45"/>
                <counts group_id="E2" events="17" subjects_affected="11" subjects_at_risk="45"/>
                <counts group_id="E3" events="13" subjects_affected="8" subjects_at_risk="43"/>
                <counts group_id="E4" events="13" subjects_affected="8" subjects_at_risk="43"/>
                <counts group_id="E5" events="5" subjects_affected="4" subjects_at_risk="42"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E7" events="5" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" events="7" subjects_affected="4" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <description>Respiratory</description>
                <counts group_id="E1" events="19" subjects_affected="14" subjects_at_risk="45"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E6" events="6" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>G Mark Grubb, RN, CCRA</name_or_title>
      <organization>Boston Scientific Corp.</organization>
      <phone>+1 (412) 716-0717</phone>
      <email>grubbm@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

